首页 | 本学科首页   官方微博 | 高级检索  
     

广泛性焦虑症病人生物反馈辅助治疗的应用
引用本文:高旭芳,朱祥路,邹涛. 广泛性焦虑症病人生物反馈辅助治疗的应用[J]. 临床神经电生理学杂志, 2009, 18(4): 244-246
作者姓名:高旭芳  朱祥路  邹涛
作者单位:1. 武汉长江航运总医院
2. 贵阳医学院精神病学教研室,贵州贵阳,550004
摘    要:目的:探讨生物反馈辅助治疗广泛性焦虑症病人的疗效。方法:将60例广泛性焦虑症病人随机分为两组:反馈治疗组(A组)和单纯药物治疗组(B组),两组各30例。A组和B组均给予抗焦虑药物帕罗西汀10~20mg/d,A组同时行生物反馈治疗,每日1次,每次30min,每周5次,连续2周后评定疗效。疗效用90项症状因子自评量表(SCL-90)评定。结果:治疗两周后,两组SCL-90评分均较人组时显著降低。A组比B组疗效更显著,其间差异有统计学意义(P〈0.05)。结论:对于广泛性焦虑症,在抗抑郁药物治疗的基础上辅以生物反馈治疗的疗效优于单纯抗抑郁药物治疗。

关 键 词:生物反馈  广泛性焦虑症  帕罗西汀  疗效

An application of biofeedback assistire treatment in patients with general anxiety disorder
GAO Xufang,ZHU Xianglu,ZHOU Tao. An application of biofeedback assistire treatment in patients with general anxiety disorder[J]. Journal of Clinical Electroneurophysiology, 2009, 18(4): 244-246
Authors:GAO Xufang  ZHU Xianglu  ZHOU Tao
Affiliation:GAO Xufang, ZHU Xianglu, ZHOU Tao(Research section of Psychiatry, Guiyang Medical College, Guiyang(550004 ) , Guizhou China)
Abstract:Objective:To study the effect of biofeedback assistive treatment in patients with general anxiety disorder(GAD). Methods. Sixty patients with GAD(CCMD-3 criteria) were divided randomly in two groups the biofeedback treatment group (Group A) and the pure drug treatment group (Group B) 30 cases in each, After two weeks accepted treatment of paroxetine (10-20 mg/d) in Group A and B,and 10 times of the biofeedback in Group A,the SCL-90 scores were employed for assessing the efficacy of the treatment in the patients with GAD. Results: At the end of treatments,the scores of SCL-90 in the two groups decreased significantly compared with the baseline(P〈 0, 05), and the efficacy for Group A is more obvious than that for Group B(P〈0.05). Conclusion: The biofeedback treatment combined with drugs is more effective than purdrug treatment in the efficacy of GAD.
Keywords:Biofeedback  General anxiety disorder(GAD)  Paroxetine  Efficacy
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号